KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Asset Utilization Ratio (2016 - 2025)

TherapeuticsMD's Asset Utilization Ratio history spans 14 years, with the latest figure at 0.08 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 76.21% year-over-year to 0.08; the TTM value through Dec 2025 reached 0.08, up 76.21%, while the annual FY2025 figure was 0.08, 84.29% up from the prior year.
  • Asset Utilization Ratio reached 0.08 in Q4 2025 per TXMD's latest filing, up from 0.07 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.33 in Q3 2023 to a low of 0.03 in Q2 2024.
  • Average Asset Utilization Ratio over 5 years is 0.35, with a median of 0.23 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: soared 830.44% in 2023, then tumbled 97.82% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.46 in 2021, then surged by 35.95% to 0.62 in 2022, then plummeted by 95.19% to 0.03 in 2023, then skyrocketed by 49.69% to 0.04 in 2024, then surged by 76.21% to 0.08 in 2025.
  • Per Business Quant, the three most recent readings for TXMD's Asset Utilization Ratio are 0.08 (Q4 2025), 0.07 (Q3 2025), and 0.07 (Q2 2025).